PT Royal Prima Tbk (IDX:PRIM)
Indonesia
· Delayed Price · Currency is IDR 74.00
-2.00 (-2.63%)
At close: Mar 6, 2026
PT Royal Prima Tbk Revenue
PT Royal Prima Tbk had revenue of 83.49B IDR in the quarter ending September 30, 2025, with 2.85% growth. This brings the company's revenue in the last twelve months to 332.14B, up 11.50% year-over-year. In the year 2024, PT Royal Prima Tbk had annual revenue of 299.36B with 12.82% growth.
Revenue (ttm)
332.14B
Revenue Growth
+11.50%
P/S Ratio
0.75
Revenue / Employee
441.67M
Employees
752
Market Cap
250.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 299.36B | 34.02B | 12.82% |
| Dec 31, 2023 | 265.34B | 3.40B | 1.30% |
| Dec 31, 2022 | 261.93B | -338.03B | -56.34% |
| Dec 31, 2021 | 599.96B | 339.37B | 130.23% |
| Dec 31, 2020 | 260.59B | 86.37B | 49.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Cipta Sarana Medika Tbk | 134.19B |
| PT Kedoya Adyaraya Tbk | 448.65B |
| PT Charlie Hospital Semarang Tbk | 58.84B |
| PT Bundamedik Tbk | 1,552.63B |
| PT Murni Sadar Tbk | 1,262.79B |
| PT Sarana Meditama Metropolitan Tbk | 1,792.36B |
| PT Lippo Karawaci Tbk | 8,843.89B |
| PT Famon Awal Bros Sedaya Tbk | 2,297.82B |